Arseny D. Moralev
Novosibirsk, NVS 630090, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Reversing the Irreversible: miRNA-Targeting Mesyl Phosphoramidate Oligonucleotides Restore Sensitivity to Cisplatin and Doxorubicin of KB-8-5 Epidermoid Carcinoma Cells.
Journal: Biomedicines
Published: November 18, 2025
Soloxolone N-3-(Dimethylamino)propylamide Suppresses Tumor Growth and Mitigates Doxorubicin-Induced Hepatotoxicity in RLS40 Lymphosarcoma-Bearing Mice.
Journal: International journal of molecular sciences
Published: November 07, 2025
Novel Cross-Cancer Hub Genes in Doxorubicin Resistance Identified by Transcriptional Mapping.
Journal: Biomedicines
Published: August 18, 2025
Sesquiterpene Lactones as Promising Anti-Glioblastoma Drug Candidates Exerting Complex Effects on Glioblastoma Cell Viability and Proneural-Mesenchymal Transition.
Journal: Biomedicines
Published: November 27, 2024
Synthesis and exploration of anticancer potential of spirocyclic 1,2,3-triazoline and aziridine derivatives of natural eudesmanolide isoalantolactone.
Journal: Bioorganic chemistry
Published: October 17, 2024
Soloxolone N-3-(Dimethylamino)propylamide Restores Drug Sensitivity of Tumor Cells with Multidrug-Resistant Phenotype via Inhibition of P-Glycoprotein Efflux Function.
Journal: Molecules (Basel, Switzerland)
Published: September 17, 2024
Complex Inhibitory Activity of Pentacyclic Triterpenoids against Cutaneous Melanoma In Vitro and In Vivo: A Literature Review and Reconstruction of Their Melanoma-Related Protein Interactome.
Journal: ACS pharmacology & translational science
Published: July 18, 2024
Novel Epoxides of Soloxolone Methyl: An Effect of the Formation of Oxirane Ring and Stereoisomerism on Cytotoxic Profile, Anti-Metastatic and Anti-Inflammatory Activities In Vitro and In Vivo.
Journal: International journal of molecular sciences
Published: May 09, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026